Penny Stock Alert: These 4 Small Cap Stocks Are Worth Big Attention Today

NEW YORK, NY / ACCESSWIRE / April 28, 2016 / The OTC Expert is issuing a report on four stocks that are trading with heavier than usual volume. MWOG, PPCH, FDBL and SUNEQ are on high volume watch, particularly MWOG. Continue reading to find out why these stocks are getting so much interest today. – If you want reports on the day’s hottest stocks (NYSE/Nasdaq/OTC) subscribe to our newsletter at otc-expert.com.

Midwest Oil and Gas Inc. (OTC: MWOG) Is an exploration stage company that engages in the exploration, development, and production of onshore oil and natural gas reserves.

When we first reported you on MWOG, shares were trading higher yesterday by over 1200% and ended up closing the day up over 600% on the day.

The stock brought in a lot of volume yesterday and it didn’t go unnoticed. We expect to see MWOG to continue to get a boost from the extra attention today, however, at a much more subdued and steady pace…

Subscribe Free To Receive Alerts Like These Sent To Your Inbox Get Your Free Membership Now.

Ascent Solar Technologies, Inc. (OTCQB: PPCH) Is a development stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic and colorectal cancer in Australia.

When we first alerted you on PPCH, shares had been on a steady rise ever since announcing last week that it had filed two more patent applications in the United States regarding new compositions of its lead product, PRP, for treating cancer.

However, yesterday, the stock gave back some of its recent gains, dropping about 9%. This was somewhat expected as it had hit overbought levels the day before, with an RSI (relative strength index) of 71.

Like What You See? Get These Alerts and Many More on NASDAQ Companies before They Rally, Find Out More Here.

Friendable, Inc. (OTC: FDBL) The company develops and disseminates a proximity based mobile-social media application that facilitates connections between people.

FDBL recently announced that their app has now achieved over 1 Million total downloads and over the past two trading days, the stock has exploded up almost 200% off massive volume.

If FDBL can continue to earn the amount of volume that it has been receiving, we believe it will continue to make these kinds of jaw dropping gains.

However, with an overbought RSI indicator of over 95, it might be time for this one to pull back a bit.

Get the Information You Need To Stay Informed and Up To Date On The Hottest NASDAQ Plays Get Them Here.

SunEdison, Inc. (OTC: SUNEQ) Is a renewable energy development company, develops, finances, installs, owns, and operates renewable power plants to residential, commercial, government, and utility customers.

Shares of SUNEQ (originally SUNE) have been in a world of hurt in 2016 and it only got worse when the company announced that it had filed for bankruptcy.

We have been following SUNEQ for quite a while now and believe that the stock isn’t going to perform until the company fixes both its financial and managerial issues.

NASDAQ Stock Alerts: Check Them Out Here To Receive Our Winning NASDAQ & NYSE Stock Alerts For Free.

About otc-expert.com

The OTC Expert is a newsletter alert service that focuses on companies on the NASDAQ & NYSE. We only highlight quality companies with big news on high volume days. This commitment provides our subscribers with only the best recommendations of companies for short and long-term investments.

To receive free text message alerts on your phone, compose a new text message to the number 95577 with the word “OTCLEADER”.

Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor’s or other person’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The OTC Expert has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words “anticipate,” “intend,” “estimate,” “believe,” “expect,” “plans,” “should,” “potential,” “forecast,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company’s actual results could differ materially from those described in any forward-looking statements contained herein. The OTC Expert is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit otc-expert.com/disclaimer website for a more detailed discussion of risks and disclosures.

Contact:

Justin Skibinski
The OTC Expert
info@otc-expert.com

SOURCE: The OTC Expert

ReleaseID: 439332